首页> 外文期刊>Diabetes >Induction of GAD65-Specific Regulatory T-Cells Inhibits Ongoing Autoimmune Diabetes in Nonobese Diabetic Mice
【24h】

Induction of GAD65-Specific Regulatory T-Cells Inhibits Ongoing Autoimmune Diabetes in Nonobese Diabetic Mice

机译:GAD65特异性调节性T细胞的诱导抑制非肥胖糖尿病小鼠正在进行的自身免疫性糖尿病。

获取原文
获取原文并翻译 | 示例
       

摘要

IDDM is a T-cell-mediated autoimmune disease in which the insulin-producing β-cells are destroyed. The disease process is complex, involving the recognition of several β-cell autoantigens. One of these, GAD65, appears to have a critical and not fully defined role in IDDM in humans and in the NOD mouse. We provide evi- Dence that an ongoing diabetogenic response in NOD Mice can be suppressed after intravenous administra- Tion of GAD65, but not by other β-cell autoantigens. Furthermore, suppression of the diabetogenic response Is mediated by the induction of GAD65-specific CD4~+ Regulatory T-cells. Finally, cytokine analysis indicates That these CD4~+ regulatory T-cells have a T-helper 2 Phenotype.
机译:IDDM是一种T细胞介导的自身免疫性疾病,其中产生胰岛素的β细胞被破坏。疾病过程很复杂,涉及几种β细胞自身抗原的识别。其中之一GAD65在人和NOD小鼠的IDDM中似乎起着至关重要的作用,但尚未完全定义。我们提供的证据表明,静脉内施用GAD65后,NOD小鼠正在进行的糖尿病反应可以被抑制,而其他β细胞自身抗原则不能。此外,通过诱导GAD65特异性CD4〜+调节性T细胞来介导抑制糖尿病的发生。最后,细胞因子分析表明这些CD4 +调节性T细胞具有T辅助2表型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号